Copyright Reports & Markets. All rights reserved.

Global Cell Expansion Technologies Market Research Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Cell Expansion Technologies Industry
  • 1.7 COVID-19 Impact: Cell Expansion Technologies Market Trends

    • 2 Global Cell Expansion Technologies Quarterly Market Size Analysis

    • 2.1 Cell Expansion Technologies Business Impact Assessment - COVID-19
      • 2.1.1 Global Cell Expansion Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Cell Expansion Technologies Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Cell Expansion Technologies Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Cell Expansion Technologies Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Cell Expansion Technologies Market
    • 3.4 Key Players Cell Expansion Technologies Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Cell Expansion Technologies Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Reagents
      • 1.4.2 Media
      • 1.4.3 Sera
      • 1.4.4 Disposables
    • 4.2 By Type, Global Cell Expansion Technologies Market Size, 2019-2021

    5 Impact of Covid-19 on Cell Expansion Technologies Segments, By Application

    • 5.1 Overview
      • 5.5.1 Clinical diagnostics
      • 5.5.2 Drug discovery and development
      • 5.5.3 Regenerative medicine
      • 5.5.4 Others
    • 5.2 By Application, Global Cell Expansion Technologies Market Size, 2019-2021
      • 5.2.1 By Application, Global Cell Expansion Technologies Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Becton
      • 7.1.1 Becton Business Overview
      • 7.1.2 Becton Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.1.3 Becton Cell Expansion Technologies Product Introduction
      • 7.1.4 Becton Response to COVID-19 and Related Developments
    • 7.2 Dickinson
      • 7.2.1 Dickinson Business Overview
      • 7.2.2 Dickinson Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.2.3 Dickinson Cell Expansion Technologies Product Introduction
      • 7.2.4 Dickinson Response to COVID-19 and Related Developments
    • 7.3 GE Healthcare
      • 7.3.1 GE Healthcare Business Overview
      • 7.3.2 GE Healthcare Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.3.3 GE Healthcare Cell Expansion Technologies Product Introduction
      • 7.3.4 GE Healthcare Response to COVID-19 and Related Developments
    • 7.4 Thermo Fisher Scientific Inc.
      • 7.4.1 Thermo Fisher Scientific Inc. Business Overview
      • 7.4.2 Thermo Fisher Scientific Inc. Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.4.3 Thermo Fisher Scientific Inc. Cell Expansion Technologies Product Introduction
      • 7.4.4 Thermo Fisher Scientific Inc. Response to COVID-19 and Related Developments
    • 7.5 Corning Inc
      • 7.5.1 Corning Inc Business Overview
      • 7.5.2 Corning Inc Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.5.3 Corning Inc Cell Expansion Technologies Product Introduction
      • 7.5.4 Corning Inc Response to COVID-19 and Related Developments
    • 7.6 Danaher Corp
      • 7.6.1 Danaher Corp Business Overview
      • 7.6.2 Danaher Corp Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.6.3 Danaher Corp Cell Expansion Technologies Product Introduction
      • 7.6.4 Danaher Corp Response to COVID-19 and Related Developments
    • 7.7 Merck Millipore
      • 7.7.1 Merck Millipore Business Overview
      • 7.7.2 Merck Millipore Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.7.3 Merck Millipore Cell Expansion Technologies Product Introduction
      • 7.7.4 Merck Millipore Response to COVID-19 and Related Developments
    • 7.8 Terumo BCT
      • 7.8.1 Terumo BCT Business Overview
      • 7.8.2 Terumo BCT Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.8.3 Terumo BCT Cell Expansion Technologies Product Introduction
      • 7.8.4 Terumo BCT Response to COVID-19 and Related Developments
    • 7.9 STEMCELL Technologies
      • 7.9.1 STEMCELL Technologies Business Overview
      • 7.9.2 STEMCELL Technologies Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.9.3 STEMCELL Technologies Cell Expansion Technologies Product Introduction
      • 7.9.4 STEMCELL Technologies Response to COVID-19 and Related Developments
    • 7.10 Sigma-Aldrich Corp
      • 7.10.1 Sigma-Aldrich Corp Business Overview
      • 7.10.2 Sigma-Aldrich Corp Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.10.3 Sigma-Aldrich Corp Cell Expansion Technologies Product Introduction
      • 7.10.4 Sigma-Aldrich Corp Response to COVID-19 and Related Developments
    • 7.11 Miltenyi Biotec
      • 7.11.1 Miltenyi Biotec Business Overview
      • 7.11.2 Miltenyi Biotec Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.11.3 Miltenyi Biotec Cell Expansion Technologies Product Introduction
      • 7.11.4 Miltenyi Biotec Response to COVID-19 and Related Developments
    • 7.12 Life Technologies
      • 7.12.1 Life Technologies Business Overview
      • 7.12.2 Life Technologies Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.12.3 Life Technologies Cell Expansion Technologies Product Introduction
      • 7.12.4 Life Technologies Response to COVID-19 and Related Developments
    • 7.13 Replicell
      • 7.13.1 Replicell Business Overview
      • 7.13.2 Replicell Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.13.3 Replicell Cell Expansion Technologies Product Introduction
      • 7.13.4 Replicell Response to COVID-19 and Related Developments
    • 7.14 Neximmune
      • 7.14.1 Neximmune Business Overview
      • 7.14.2 Neximmune Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.14.3 Neximmune Cell Expansion Technologies Product Introduction
      • 7.14.4 Neximmune Response to COVID-19 and Related Developments
    • 7.15 TC Biopharm
      • 7.15.1 TC Biopharm Business Overview
      • 7.15.2 TC Biopharm Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.15.3 TC Biopharm Cell Expansion Technologies Product Introduction
      • 7.15.4 TC Biopharm Response to COVID-19 and Related Developments
    • 7.16 Pluristem Therapeutics
      • 7.16.1 Pluristem Therapeutics Business Overview
      • 7.16.2 Pluristem Therapeutics Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.16.3 Pluristem Therapeutics Cell Expansion Technologies Product Introduction
      • 7.16.4 Pluristem Therapeutics Response to COVID-19 and Related Developments
    • 7.17 ReNeuron
      • 7.17.1 ReNeuron Business Overview
      • 7.17.2 ReNeuron Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.17.3 ReNeuron Cell Expansion Technologies Product Introduction
      • 7.17.4 ReNeuron Response to COVID-19 and Related Developments
    • 7.18 Voria Biomaterials
      • 7.18.1 Voria Biomaterials Business Overview
      • 7.18.2 Voria Biomaterials Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.18.3 Voria Biomaterials Cell Expansion Technologies Product Introduction
      • 7.18.4 Voria Biomaterials Response to COVID-19 and Related Developments
    • 7.19 CellProthera
      • 7.19.1 CellProthera Business Overview
      • 7.19.2 CellProthera Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.19.3 CellProthera Cell Expansion Technologies Product Introduction
      • 7.19.4 CellProthera Response to COVID-19 and Related Developments
    • 7.20 Cytomatrix
      • 7.20.1 Cytomatrix Business Overview
      • 7.20.2 Cytomatrix Cell Expansion Technologies Quarterly Revenue, 2020
      • 7.20.3 Cytomatrix Cell Expansion Technologies Product Introduction
      • 7.20.4 Cytomatrix Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Cell Expansion Technologies, including the following market information:
      Global Cell Expansion Technologies Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cell Expansion Technologies Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cell Expansion Technologies Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cell Expansion Technologies Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Becton, Dickinson, GE Healthcare, Thermo Fisher Scientific Inc., Corning Inc, Danaher Corp, Merck Millipore, Terumo BCT, STEMCELL Technologies, Sigma-Aldrich Corp, Miltenyi Biotec, Life Technologies, Replicell, Neximmune, TC Biopharm, Pluristem Therapeutics, ReNeuron, Voria Biomaterials, CellProthera, Cytomatrix, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Reagents
      Media
      Sera
      Disposables

      Based on the Application:
      Clinical diagnostics
      Drug discovery and development
      Regenerative medicine
      Others

      Buy now